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Liver ERα regulates AgRP neuronal 
activity in the arcuate nucleus of 
female mice
Valeria Benedusi1,2, Sara Della Torre1,2, Nico Mitro  1, Donatella Caruso1, Alessandra Oberto4, 
Claire Tronel3, Clara Meda1 & Adriana Maggi1,2
Recent work revealed the major role played by liver Estrogen Receptor α (ERα) in the regulation 
of metabolic and reproductive functions. By using mutant mice with liver-specific ablation of Erα, 
we here demonstrate that the hepatic ERα is essential for the modulation of the activity of Agouti 
Related Protein (AgRP) neurons in relation to the reproductive cycle and diet. Our results suggest that 
the alterations of hepatic lipid metabolism due to the lack of liver ERα activity are responsible for a 
neuroinflammatory status that induces refractoriness of AgRP neurons to reproductive and dietary 
stimuli. The study therefore points to the liver ERα as a necessary sensor for the coordination of 
systemic energy metabolism and reproductive functions.
It is well known that, in the animal kingdom, metabolic and reproductive functions are strictly associated, prin-
cipally in female organisms. In mammals, specific brain nuclei located in the hypothalamic region play a major 
role in such integration. In particular, the neurons expressing the orexigenic peptide AgRP in the arcuate nucleus 
of the hypothalamus (ARC) appear to represent an important crossroad for the selective detection and regulation 
of nutritional and reproductive functions, in virtue of their ability to regulate appetite and energy metabolism in 
response to estrogens and to interact with other neuronal systems (such as the Kisspeptin (Kiss1) secreting neu-
rons)1–3 that regulate the secretion of the gonadotropin-releasing hormone (GnRH)4.
The ERα is highly expressed in this nucleus and estrogens are known to play a major modulatory action in the 
secretion of factors regulating female energy metabolism and reproductive functions5–7.
On the other hand, it is now becoming evident that, all along the course of phylogenesis, the liver (or the 
organs carrying out its function in less evolved animals) has been a key element for the integration of reproduc-
tive and metabolic activities. In fact, in oviparous and viviparous animals, nutritionally favorable conditions are 
indispensable for the synthesis of the liver proteins necessary for the maturation of the egg8. In mammals, liver 
appears to have amplified its cross-relation with the reproductive system by acquiring the capability to adapt 
its metabolism to the alternating necessities of the numerous phases of reproduction (ovulation, pregnancy, 
lactation)8. Liver ERα was suggested to act as the sensor of the changes occurring during reproduction and a 
regulator of reproduction-associated metabolism. Indeed, in the course of the different reproductive stages, the 
transcriptional activity of liver ERα is regulated, via unliganded and liganded activation, by dietary aminoacids 
and circulating estrogens9, 10 and this results in significant changes of lipid metabolism and transport10–15 and of 
the synthesis of the factors indispensable for the progression of the reproductive cycle (e.g. Insulin-like growth 
Factor-1, IGF-1)9, 10, 16. Thus, in view of their paired activity, a functional interconnection between the liver and 
AgRP neurons is conceivable, recent studies demonstrated that AgRP neurons regulate nutrient partitioning in 
liver through neuronal projections to preganglionic structures17, 18, but still unknown is whether the liver is able 
to influence the activity of AgRP neurons, in spite of the fact that these ARC cells were reported to be very sensi-
tive to signaling of other peripheral organs relevant for energy metabolism, such as pancreas, adipose tissue and 
others19–26.
Considering the role of ERα in the control of liver homeostasis in response to reproductive and environmental 
cues, the aim of the present study was to evaluate whether the activity of this receptor has any influence on the 
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function of the hypothalamic neurons of the AgRP/Kiss1 circuit. We here show that the ablation of liver Erα is 
associated with changes in the activity of AgRP neurons, thus pointing to the existence of a liver-hypothalamic 
circuit potentially relevant for the mutual control of energy expenditure and reproduction in mammals.
Results
In LERKO mice the activity of AgRP neurons fails to be regulated by the estrous cycle. Studies 
carried out in several laboratories, including ours, showed that AgRP mRNA fluctuates in the course of the repro-
ductive cycle7, 27. We therefore investigated the extent to which liver ERα ablation influenced AgRP synthesis. As 
the estrous cycle in mouse lasts only 4 days and the extent of circulating estrogens may vary significantly within 
a day, animals were euthanized following a precise protocol in which the phase of the cycle was established by 
vaginal smears between 9 and 10 a.m., and the animals were euthanized between 2 and 5 p.m.
Using the same experimental settings, prior experiments showed that in the whole hypothalamus the concen-
tration of AgRP mRNA increased significantly in the course of estrous (E), while at proestrus (P), metestrus (M) 
and diestrus (D) was the same27. Consistent with the previous findings, Fig. 1A shows that in the hypothalamus 
of the floxed mice the content of the AgRP mRNA at E was the highest (+78% versus P, +59% versus M). In 
LERKO mice, AgRP mRNA content did not change in the course of the reproductive cycle (Fig. 1A). This could 
not be ascribed to a decreased expression of ERα in the hypothalamus, as demonstrated by the measurement of its 
mRNA during the cycle (Suppl. Fig. 1). To evaluate the extent to which the amount of AgRP mRNA reflected the 
activity of AgRP neurons, we carried out an IHC study (Representative images in Fig. 1B, upper panel) counting 
the number of terminals of neurons positive to AgRP immunostaining at E and M in the ARC (Fig. 1B, lower 
panel). In floxed female mice, the AgRP immunoreactivity at E was significantly higher than at M (+57%), in 
LERKO the immunoreactivity was as low as at M in the floxed counterpart and did not change at E supporting the 
previous results obtained in the whole hypothalamus (Fig. 1B, lower panel). No changes in AgRP immunoreactiv-
ity were observed in the paraventricular nucleus (PVN) of floxed and LERKO mice (Suppl. Fig. 2A).
We knew that the fluctuation of circulating estrogens is unaffected by the LERKO mutation11, thus the insensi-
tivity of LERKO AgRP neurons to the alternation of the phases of the cycle could not be ascribed to alterations of 
circulating gonadal hormones, but had to be associated with factors dependent on liver ERα activity.
We next measured other hypothalamic mRNAs implicated in the control of energy metabolism. Neuropeptide 
Y (NPY) mRNA showed a trend to a fluctuation in floxed, but not in LERKO mice (Fig. 1C). Conversely, the 
anorexigenic cocaine-amphetamine-regulated transcript (CART) mRNA (Fig. 1D) and proopiomelanocortin 
(POMC) mRNA and protein (Fig. 1E and Suppl. Fig. 2B) did not show any measurable change associated with 
the phases of the cycle in both floxed and LERKO mice. Since it is known that the activity of the Kiss1 neurons is 
sensitive to estrogen28 and metabolic signals29, 30, we measured also Kiss1 mRNA content. As previously reported 
for animals in which liver ERα is expressed27, Kiss1 mRNA was the same at E and M in both floxed and LERKO 
mice (Fig. 1F), thus pointing to the fact that AgRP neurons are specifically affected by the progression of the cycle 
and by the absence of Erα expression in the liver.
The refractoriness of LERKO AgRP neurons to the drop of circulating estrogens is associated 
with significant changes in microglia morphology. In spite of the lower content of orexigenic AgRP in 
the ARC, female LERKO mice are not leaner than their syngenic counterpart and show a comparable food intake 
(Suppl. Fig. 3), this was anticipated on the bases of prior reports showing that neonatal mutations affecting AgRP/
NPY neuron signaling induce compensative responses that abolish the effect of the genetic alteration17, 30–32.
On the other hand, several laboratories reported that the diet may induce alteration of the activity of AgRP/
NPY neurons in association with local neuroinflammation33, 34: this effect is sexually dimorphic, as female mice 
appear to be less susceptible than males to such dietary effects and this insensitivity appears to be ERα-mediated35. 
This led us to investigate the state of neuroinflammation in the ARC of LERKO mice. We stained brains isolated 
from floxed and LERKO mice with antibodies against glial fibrillary protein (GFAP) and Ionized calcium binding 
adaptor molecule 1 (Iba1). The experiment was carried out in mice at E, as this is the phase in which we could 
best appreciate the unresponsiveness of LERKO AgRP neurons to the drop of circulating estrogens. The staining 
with the anti-GFAP antibody revealed that astrocytes were barely detectable in both floxed and LERKO and that 
their morphology was unaffected by the liver ablation of Erα (Fig. 2A). On the other hand, anti-Iba1 antibody 
immunoreaction showed that, in LERKO mice, microglia had a heterogeneous morphology and numerous cells 
had thicker and shorter branches (Fig. 2B, upper panel), indicative of the initial stages of conversion toward an 
overt inflammatory phenotype. It is in fact known that, in its surveilling status, microglia has thin and rami-
fied branches that need to be retracted to enable the cell to acquire the globular phenotype characteristic of the 
response to an inflammatory stimulus (Fig. 2B, middle panel). Morphometric analysis of microglia showed that, 
in floxed mice, 98% of microglia was in the resting phenotype (A–C) and only 2% appeared to be in an initial 
stage of inflammation (D–E). This was expected, as these mice were females maintained in a standard diet. In 
LERKO mice 33% of the cells were resting (A–C), 59% showed an initial stage of activation (D–E), 8% were clearly 
activated (F) (Fig. 2B, lower panel). Further density analysis of these ARC cells showed that the number of cells 
was the same in floxed and LERKO mice (Fig. 2C, lower panel).
Thus microglia in LERKO appeared to be primed to activation. This finding was in line with previous studies 
associating neuroinflammation with an alteration of AgRP neuron activity34, 36–38. Interestingly, neuroinflamma-
tion was circumscribed to the brain area where the AgRP neurons are located, because no alterations in LERKO 
microglia morphology were observed in the dorsal-medium (DMH), lateral hypothalamus (LH), ventro-medial 
hypothalamus (VMH) and ventro-medial dorso-medial hypothalamus (VMDMH) (Suppl Fig. 4).
When we attempted to quantify the extent to which microglia priming was associated with the presence of 
inflammatory molecules, we failed to measure a significant increase in the hypothalamic content of mRNAs 
encoding molecules of the inflammatory cascade such as Macrophage Antigen Complex-1 (MAC1), CD11c, 
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Figure 1. AgRP mRNA synthesis does not fluctuate during the estrous cycle in LERKO mice. AgRP mRNA 
measured by Real Time PCR in the hypothalamus of floxed and LERKO mice during the different phases of the 
estrous cycle, protestrus (P), estrous (E), metestrus (M) and diestrus (D) (A), representative images of AgRP 
staining in the arcuate nucleus of floxed and LERKO mice at E and quantification of AgRP positive synaptic 
puncta as evaluated by IHC for AgRP protein in the ARC of floxed and LERKO female mice at E (B), NPY 
mRNA (C), CART mRNA (D), POMC mRNA (E) and KISS1 mRNA (F) measured by Real Time PCR in the 
hypothalamus of floxed and LERKO female mice in E and M. 3 V = third ventricle. The image of the brain slice 
in Fig. 1B shows the areas used for the morphological analyses (from −1.70 mm to −1.58 mm from bregma) 
and is adapted from the web site: http://www.hms.harvard.edu/research/brain/atlas.html. The morphometric 
analysis was done as described in the methodology section. Data shown are the combined result of 2 separate 
experiments each with the following number of animals: rtPCR: n = 4 mice/exp for floxed, n = 8 mice/exp for 
LERKO. IHC: n = 3 mice/exp for floxed, n = 5 mice/exp for LERKO, Data are represented as mean ± SEM. 
Figure 1A: **p < 0.01, two-way ANOVA followed by Bonferroni post hoc test, p = 0.0236, DF = 1, F = 5.84, 
LERKO vs floxed, °P < 0.05, p = 0.5918, DF = 3, F = 0.65, P vs E vs M vs D, but the interaction between the two 
variables is significant (p = 0.0284). Figure 1B: *p < 0.05, two-way ANOVA followed by Bonferroni post hoc 
test, p = 0.0342, DF = 1, F = 6, LERKO vs FLOXED, °p < 0.05, unpaired two-tailed t-test, p = 0.0147, DF = 1, 
t = 8.161, E vs M. Figure 1C: p = 0.3076, DF = 1, F = 1.09, LERKO vs floxed, p = 0.3555, DF = 1, F = 0.89, 
Fig. 1D: p = 0.5608, DF = 1, F = 0.36, LERKO vs floxed, p = 0.6709, DF = 1, F = 0.19, E vs M, Fig. 1E: p = 0.9114, 
DF = 1, F = 0.01, LERKO vs floxed, p = 0.3957, DF = 1, F = 0.79, E vs M, Fig. 1F: p = 0.4722, DF = 1, F = 0.54, 
LERKO vs floxed, p = 0.5109, DF = 1, F = 0.45, E vs M.
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Interleukin-6 (IL6) and Macrophage Chemoattractant Protein-1 (MCP1) in the LERKO hypothalamus (Suppl. 
Fig. 5). We attributed this result to the fact that such a measurement was done in the entire hypothalamic region, 
while the area affected by the change was restricted to the ARC.
High fat diet fails to activate microglia in LERKO mice. The finding of a primed microglia in the 
ARC of LERKO animals led us to hypothesize that, in these mutant mice, ARC microglia was more susceptible 
to inflammatory stimuli than floxed mice microglia. We tested this by exposing floxed and LERKO mice to HFD 
(60% Kcal derived from fat) for a period known to induce neuroinflammation (4 months). As HFD leads to a 
decrease of AgRP synthesis and increased inflammation39–43, in this experiment we devised to euthanize the mice 
at M because in this phase the activity of AgRP neurons was equally low in the two genotypes and this would 
have allowed us to better distinguish the diet-induced effect. Figure 3A shows that, in both genotypes, HFD did 
not modify the number of Iba1 positive cells. In floxed mice, the exposure to HFD increased significantly the 
number of cells with a less ramified phenotype (100% A–C in ND vs 38.7% A–C, 58.6% D–E, 2.8% F in HFD), 
this distribution of phenotypes was similar to what observed in LERKO in normal diet (36.8% A–C, 55% D–E, 
8.2% F) (Fig. 3B). Unexpectedly, the HFD did not cause noticeable changes in LERKO microglia (31.1% A–C, 
57.5% D–E, 11.2% F) (Fig. 3B and C), suggesting that the lack of ERα activity in the liver blunted the ability of 
ARC cells to sense the presence of diet-induced inflammatory stimuli. Again, we did not observe a change of the 
mRNAs of the proinflammatory molecules MAC-1, CD11c, IL-6 and MCP-1 in the entire hypothalamus (Suppl. 
Figure 2. The absence of hepatic ERα affects the morphology of microglia, but not astrocytes. Representative 
images of astrocytes in the arcuate nucleus of floxed and LERKO mice stained with an anti-GFAP Ab (A), 
upper: representative images of microglia in the arcuate nucleus of FLOXED and LERKO mice at E stained with 
anti Iba1 Ab, middle: morphology of microglia at different stages of activation adapted from Kreutzberg et al., 
Trends is Neuroscience (1996)83, lower: percentages of microglia distribution across different phenotypes (B), 
percentage of Iba1-positive cells in the different stages of microglia activation in the arcuate nucleus of FLOXED 
and LERKO mice at E (C). Data shown are the combined result of 2 separate experiments (n = 5 mice/group/
experiment). Data are represented as mean ± SEM. Figure 2B: °p < 0.05, °°°p < 0.001, ***p < 0.001, one-way 
ANOVA followed by Bonferroni post hoc test. p < 0.0001, DF = 2, F = 31.18 A–C vs D–E vs F, p = 1, DF = 1, 
F = 0 LERKO vs FLOXED, but the interaction between the two variables is significant (p < 0.0001). Figure 2C: 
p = 0.7855, DF = 17, t = 0.2765, two-tailed unpaired t-test.
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Fig. 6). When we measured AgRP mRNA and counted the AgRP immunostained puncta we found no statistically 
significant differences between floxed and LERKO mice (Fig. 3D and E) maintained with the standard diet, this 
is in line with what expected in animals at M. HFD reduced AgRP mRNA and AgRP positive synaptic puncta in 
floxed, but not in LERKO mice (Fig. 3D and E).
Altogether the data obtained suggested that liver ERα has a role in maintaining AgRP neuron responsiveness 
to hormonal and dietary stimuli.
Figure 3. Neither microglia morphology in the ARC nor AgRP synthesis is affected by HFD in LERKO 
mice. Iba1 positive cells (A) percentages of microglia distribution across different phenotypes (B) in the 
arcuate nucleus of floxed and LERKO female mice in M after 4 months of ND or HFD, representative images 
of microglia stained with an antibody against Iba1 in the arcuate nucleus of the hypothalamus of floxed and 
LERKO female mice in metestrus after 4 months of ND or HFD (C), AgRP mRNA measured by Real Time 
PCR in the hypothalamus (D) and AgRP positive synaptic puncta, as evaluated by IHC for AgRP protein, in 
the arcuate nucleus of the hypothalamus (E) of floxed and LERKO female mice in M, after 4 weeks of ND and 
HFD. Data shown is combined results of 2 separate experiments with the following n: rtPCR: N = 5 mice/group/
exp. IHC: N = 5 mice/group/exp. Data are represented as mean ± SEM. Figure 3A: two-way ANOVA followed 
by Bonferroni post hoc test, DF = 1, F = 0.11, p = 0.7475, HFD vs ND, DF = 1, F = 0.41, p = 0.5329, LERKO 
vs Floxed. Figure 3B: °, #p < 0.05, *p < 0.01, two-way ANOVA followed by Bonferroni post hoc test, DF = 2, 
F = 12.75, p < 0.0001 A–C vs D–E vs F, DF = 3, F = 0, p = 1, LERKO vs SYN in each diet., Fig. 3D: °°p < 0.01, 
two-way ANOVA followed by Bonferroni post hoc test, DF = 1, F = 10.12, p = 0.0032 HFD vs ND, DF = 1, 
F = 0.89, p = 0.3512 LERKO vs Floxed. Figure 3E: °p < 0.05, two-way ANOVA followed by Bonferroni post hoc 
test, DF = 1, F = 10.14, p = 0.0058, HFD vs ND, DF = 1, f = 1.86, P = 0.1918, LERKO vs Floxed.
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The ablation of liver Erα is associated with plasma enrichment in molecules activating micro-
glia. Prior experiments demonstrated that liver Erα plays a major role in the control of liver lipid metabolism 
and that a lack of estrogen signaling in liver is associated with lipid accumulation11 and inflammation (manuscript 
in preparation). This led us to ask whether in LERKO mice the state of microglia inflammation in the ARC could 
be ascribed to an increased concentration of circulating inflammatory molecules. To test this hypothesis, we 
exposed microglia N9 cells to plasma isolated from floxed or LERKO mice and measured the content on mRNAs 
encoding inflammatory molecules.
In the first experiment, we added to the medium of N9 cells the plasma isolated from the mice of the two 
genotypes at E to the final concentration of 1% or 3%. As shown in Fig. 4A, incubation for 3 and 6 hours with 1% 
plasma from LERKO, but not floxed mice, induced a significant increase of IL-1β mRNA content in N9 cells. This 
effect was magnified with the increase of the concentration of plasma from 1 to 3% (+154%) (Fig. 4A). Also at 
this higher concentration the plasma from floxed mice was without any measurable effect. The increased mRNA 
content reflected a significantly higher synthesis of intracellular IL-1β protein (Fig. 4B). These results indicate 
the presence of inflammatory molecules in the plasma of LERKO but not floxed mice. The treatment of N9 cells 
with 3% plasma from LERKO mice for 6 hours did not affect Tumor necrosis factor-α (Tnf-α), Interleukin-10 (Il-
10) and Cd68 mRNA expression, while Macrophage Inflammatory Protein-2 (MIP2) mRNA showed a trend to 
increase, still not significant (Fig. 4C–F).
Since we did not see any effect with heat inactivated plasma (Suppl. Fig. 7) and we knew that hepatic lipid 
synthesis in LERKO is highly affected by liver Erα ablation, we hypothesized that the inflammatory molecules in 
LERKO plasma were of lipid nature.
As lipids activate microglia through the TLR4 receptor44, we tested whether the exposure to the TLR4 inhibi-
tor TAK242 prevented the activation induced by plasma from LERKO mice. Figure 5 shows that the response of 
N9 cells to LERKO plasma is blunted by the presence of the TLR-4 inhibitor, thus suggesting that the mediator/s 
responsible for microglia activation present in the LERKO plasma might be a lipid.
This led us to measure free and total fatty acids in the plasma of floxed and LERKO mice in E by mass spec-
trometry. Plasma content of free fatty acids was unaffected (Fig. 6A) but total palmitic acid and eicosapentaenoic 
acid (EPA) were found to be significantly increased in LERKO mice (Fig. 6B). It is known that the saturated pal-
mitic acid activates microglia and macrophages45, 46 through stimulation of TLR4 receptor45, thus suggesting its 
involvement in microglia activation in LERKO mice and in N9 cells in vitro.
Discussion
The present study shows that the liver may play a role in the peripheral signaling to the arcuate nucleus and there-
fore that this organ may contribute to the overall ability of this Central Nervous System (CNS) nucleus to respond 
to dietary stimuli. Most interestingly, liver ERα is involved in this function. Estrogens are potent regulators of 
food intake and body weight in female mammals, including women. This effect is carried out mainly through a 
genomic action of the intracellular ERα, albeit some rapid, non-genomic actions have been also reported with 
the same receptor47, 48.
Still object of investigation is the extent to which estrogens are able to regulate the synthesis and secretion of 
the peripheral endocrine molecules that regulate the activity of the central nuclei for the metabolic control. What 
it is well described so far is that estrogens in the CNS increase the sensitivity to anorexigenic molecules such as 
leptin, released by adipocytes49–52, cholecystokinin (CCK), produced by small intestine53, 54 and insulin, synthe-
sized by the pancreas51, 52 and, at the same time, decrease the response to the orexigenic peptide ghrelin from the 
gastro-intestinal tract55, 56.
In spite of its major role in energy metabolism, the liver ERα has never been reported to be involved in the 
regulation of the activity of the nuclei in the ARC relevant for energy homeostasis. Here, we demonstrate that 
the activity of AgRP neurons and of microglia in the ARC is altered following liver specific ablation of Erα. The 
molecules responsible for such signalling remain to be identified. Estrogens are known to induce the hepatic 
synthesis of IGF116 and the circulating concentration of IGF1 is significantly lower in LERKO mice than in the 
floxed ones9: this, together with the fact that IGF1 does not affect the production of IL1β by N9 microglia (data 
not shown) would rule out any IGF1 participation in the estrogen-mediated signalling of liver energetic status to 
the central nuclei. On the other hand, we know also that liver ERα controls lipid metabolism11 and in the absence 
of liver ERα stimulation or in LERKO mice there is an increase of hepatic lipid synthesis11, 57, 58. Thus it could be 
hypothesized that in LERKO mice the augmented lipid deposits in liver and altered lipoprotein composition11 
may determine the release in the circulation of a specific class of lipids able to activate microglia and influence 
the activity of AgRP neurons. Supporting the view of a lipid-based signalling are the following observations: (a) 
the phenomenon is restricted to the ARC, an area particularly exposed to fatty acid and lipid- associated mole-
cules coming from the blood, also in virtue of the highly fenestrated blood brain barrier59, (b) when we treated 
N9 cells with heat-inactivated plasma from LERKO mice, we did not observe the microglia priming induced 
by plasma from LERKO mice (Suppl. Fig. 7C); (c) TLR4, known to be activated by fatty acids60–63, is necessary 
for IL1β production by microglia upon stimulation with the plasma of LERKO mice (d) selected fatty acids (a 
polyunsaturated fatty acid, EPA, and a saturated fatty acid, palmitic acid) are increased in the plasma of LERKO 
mice. This last observation may indicate a counterregulatory mechanism: indeed docosapentaenoic acid (DHA), 
a polyunsaturated fatty acid, has been able to tackle the proinflammatory effect of palmitic acid and LPS in dif-
ferent cellular models64, 65, EPA is a precursor of DHA66, 67, thus EPA accumulation may reflect a defect in DHA 
synthesis in LERKO mice. Furthermore, Valdearcos et al. demonstrated that microglia is a key mediator linking 
excess saturated fatty acids (SFAs) intake and hypothalamic inflammation, able to regulate neuronal stress and 
hypothalamic function in relation to excess dietary intake of saturated lipids68 and, most relevant for our findings, 
microglia restrains the responsiveness of ARC neurons to leptin when SFAs consumption is high68. This is in line 
with the refractoriness of AgRP neurons to the fluctuating levels of estrogen and to the HFD observed in LERKO 
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mice, suggesting that the activated microglia in LERKO mice could be responsible for the altered function of 
AgRP neurons. We cannot rule out that, in LERKO mice, the lack of ERα influence on lipid metabolism may 
induce compensatory effects through vagal afferents described to influence the activity of arcuate nucleus69, 70.
The present study does not give a complete insight on the physiological role of the hepatic signalling to the 
ARC. The decreased activity of AgRP neurons here described in the LERKO mice did not affect body weight 
and food intake, previous studies showed that neonatal depletion of Agrp gene does not lead to anorexia while 
the acute-ablation does32, 71–73. It has been suggested that anorexia in models of acute deletion of Agrp in adult 
Figure 4. Plasma of LERKO mice induced IL1β production in N9 microglia cells while TNFα, MCP1, MIP2 
and IL10 mRNAs are unaffected. IL1β mRNA measured by Real Time PCR in N9 cells treated with 1% or 3% 
of mouse plasma of floxed and LERKO mice in E for 3 and 6 hours. (A). IL1β protein content in cell lysate from 
N9 cells treated with 3% of mouse plasma of floxed and LERKO mice in E for 6 hours (B), TNFα mRNA (C), 
IL10 mRNA (D), CD68 mRNA (E), MIP2 mRNA (F) measured by Real Time PCR in N9 cells treated with 3% 
of mouse plasma of floxed and LERKO mice in E for 6 hours. The dotted line represents the value of untreated 
N9 cells. Data shown are the combined results of 2 separate experiments (Fig. 4A,C,D and F: n = 4 wells/group/
exp, Fig. 4B: n = 2 wells/group/exp), all data are represented as mean ± SEM. The dotted lines represent the 
values of untreated cells. Figure 4A: *P < 0.05, one-way ANOVA followed by Bonferroni post hoc test, DF = 1, 
F = 11.10, p = 0.0088, N9-LERKO vs N9-SYN - treatment with 1% plasma, DF = 1, F = 0.85, p = 0.3795 3 h vs 
6 h – treatment with 3% plasma, ***p < 0.0001, DF = 23, t = 5.646, two-tailed unpaired t-test, N9-LERKO vs 
N9-SYN – 3% treatment. Figure 4B: **p = 0.0027, DF = 5, t = 5.516, two-tailed unpaired t-test. Figure 4C–F: 
no significant difference was found between the two experimental groups by two-tailed unpaired t-test, Fig. 4C: 
p = 0.3899, DF = 23, t = 0.8764, Fig. 4D: p = 0.2541, DF = 18, t = 1.178, Fig. 4E: p = 0.2541, DF = 9, t = 1.178, 
Fig. 4F: p = 0.9218, DF = 23, t = 0.09930.
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mice derives from hyperactivity of the parabrachial nucleus (PBN) due to the loss of the inhibitory GABAergic 
afferents from AgRP neurons74–76. Since AgRP afferents do not complete their neurocircuitry till 21 days of age, 
neonatal Agrp ablation does not result in PBN hyperactivity, probably due to lack of AgRP afferents in the PBN77, 
78. Neonatal knockout of Erα in LERKO mice79 may lead to an early impairment of AgRP neuronal function, thus 
allowing the establishment of compensatory mechanisms.
Considering that the ARC controls food partitioning in liver and our prior studies pointing to the hepatic ERα 
as the sensor of nutrient availability necessary to regulate energy metabolism on reproductive functions8, it is 
tempting to speculate that the liver-ARC loop plays a role for the continuous monitoring and adaptation of repro-
ductive functions upon nutrient availability. This would explain why in the absence the hepatic sensor of nutrient 
availability, ERα9, the LERKO ARC remains insensitive to the fluctuation of circulating estrogens and to HFD.
It is understandable that, during the course of evolution, reproductive functions shaped the mechanisms regu-
lating energy metabolism in female mammals, creating an intricate network of interactions indispensable for the 
understanding of the loss of homeostasis of the energy metabolism occurring in women at the end of their fertile 
life. ERα is a clear central player in such mechanistic pathways, the hypothesis that we are putting forward is that 
liver ERα might have a unique function as a sensor of nutrient availability, driver of liver metabolism and reporter 
of liver functions to the CNS. Therefore its reduced activity after the menopause may represent a major driver 
for the obesity, inflammation and associated pathologies described for women in the post-menopausal period80. 
If this were the case, the present study provides a further indication that the correct replacement therapy for the 
post-menopause would be a Selective Estrogen Receptor modulator (SERM) able to target liver to re-establish the 
functions lost with the decrease of ovarian functions.
Methods
Animals. The floxed and LERKO mice were obtained and maintained as previously described11. Unless oth-
erwise stated, the mice were 5–6 months of age at euthanasia. Vaginal smears were performed at 9:00–10:00 a.m. 
To avoid any possible confounding effect due to the circadian rhythm or feeding status, the mice were euthanized 
after 6 hours of fasting between 2:00 and 5:00 p.m.. The body weight and the food intake were calculated twice a 
week. The food intake was calculated as the amount of food consumed by the single cage averaged by the number 
of mice and the number of days, then the Kcal consumed were calculated for each diet. All animal experimenta-
tion was performed in accordance with the ARRIVE guidelines and the European guidelines for animal care and 
the use of experimental animals, approved by the Italian Ministry of Research and University, and controlled by 
a departmental panel of experts.
Diets. The control diet (ND) consisted of 4.3% fat, 67.3% carbohydrate, and 19.2% protein with 10% Kcal 
derived from fat, 70% Kcal derived from carbohydrates and 20% Kcal derived from proteins (D12450B, Research 
Diets, NJ, USA). The HFD used in the experiments consisted of 35% fat, 26% carbohydrate, and 26% protein with 
60% of Kcal derived from fat, 20% Kcal from carbohydrates and 20% Kcal from proteins (D12492, Research Diets, 
NJ, USA). Free access to the diets was provided. Mice were given ND and HFD from 2 to 6 months of age. They 
were euthanized by anaesthesia overdosing (Ketamine and xilazine) and cervical dislocation.
Blood sampling procedures. Blood was collected by cardiac puncture under profound anaesthesia and 
before cervical dislocation. EDTA 12.5 mM was added to blood immediately to prevent clotting and plasma was 
obtained by centrifugation at 8000 rpm at 4 °C. Plasma was stored at −80 °C.
Real-Time PCR Gene Expression Analysis. The hypothalami were homogenized in TRIzol® (Life 
Technologies, Carlsbad, CA), (6% w/v) using a TissueLyser (QIAGEN, Milan, Italy) while N9 cells were 
lysed with the RLT lysis provided by the RNeasy Mini Kit (QIAGEN, Milan, Italy) supplemented with 10% 
Figure 5. TLR4 is involved in the IL1β production induced in N9 cells treated with plasma of LERKO mice. 
IL1β mRNA measured by Real Time PCR in N9 cells treated with 3% of mouse plasma of floxed and LERKO 
mice in E for 6 hours with or without prior treatment with TLR4 inhibitor TAK242 10 μM 30 min before the 
plasma. Data shown is combined results of 2 separate experiments (N = 4 wells/group/exp). The dotted line 
represents the value of untreated N9 cells. All data are represented as mean ± SEM. *p < 0.05, ***p < 0.001, 
one-way ANOVA followed by Newman Keuls post hoc test, p = 0.0007, DF = 4, F = 9.794.
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Figure 6. Total palmitic acid and EPA are increased in the plasma of LERKO mice. The content of free and total 
fatty acids indicated was measured in the plasma of floxed and LERKO mice in E by LC-MS/MS. Data shown 
is combined results of 2 separate experiments (N = 4–5 mice/exp). Statistical significance was assessed by two-
tailed unpaired t-test. *p < 0.05, Fig. 6B: palmitic acid, p = 0.0327, DF = 11, t = 2.443, EPA, p = 0.0352, DF = 10, 
t = 2.434, EPA, p = 0.0352, DF = 10, t = 2.434.
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β-mercaptoethanol. RNA was purified using the RNeasy Mini Kit, according to the manufacturer’s instructions. 
cDNA synthesis, real-time PCR, and data analysis were performed as previously described81. Real time PCR anal-
yses was performed on triplicates. The primers used for the rtPCR reactions were as follows: AgRP Mm00475829_
g1, Npy (Mm03048253_m1), Cart (Mm04210469_m1), POMC (Mm00435874_m1), Kiss1 (Mm03058560_m1), 
Esr1 Mm00433147_m1, Il1β Mm00434228_m1, Tnfα (Mm00443258_m1), Il-10 (Mm00439614_m1), CD68 
Mm03047340_m1, Mip2 (Mm00436450_m1), Mac1 (Mm00434455_m1), Cd11c (Mm00498698_m1), Il-6 
(Mm00446190_m1), Mcp1 (Mm00441242_m1). Primers for the 36b4 gene were used as reference (forward: 
5′-GGCGACCTGGAAGTCCAACT-3′ and reverse: 5′-CCATCAGCACCACAGCCTTC-3′).
Histological Analysis. For AgRP, GFAP and Iba 1 analysis, brains were taken and immersed in 4% buffered 
paraformaldehyde for 24 h and then paraffin embedded. Serial sections of paraffin-embedded brains were cut at 
5 μm and used to perform different immunostainings. On selected sections, the following immunohistochemical 
stainings were carried out: Agouti Related Protein (AgRP rabbit polyclonal antibody, 1:200, Phoenix), Ionized 
calcium binding adaptor molecule 1 (Iba1 rabbit polyclonal antibody, 1: 500, Wako Chemicals) and glial fibrillary 
acidic protein (GFAP, mouse Alexa Fluor 488- conjugated monoclonal antibody, 1:1000, Chemicon). Nuclei were 
labeled with Hoechst 33342 (Sigma). For quantitative analysis, brain slices images (1300 × 1030 pixels) in the area 
of the arcuate nucleus (−1.70 mm to −1.58 mm from bregma) and of the paraventricular nucleus (−0.94 to −0.82 
from bregma) were captured using the x40 objective of a Zeiss Axioscope microscope equipped with a digital 
camera (Carl Zeiss, Thornwood, NY).
For POMC analysis brains were taken and immersed in 4% buffered paraformaldehyde for 24 h, then they 
were cryoprotected in a solution of sucrose 30% in phosphate buffer 0.1 M. Brains were cut at 25 μm and the 
immunohistochemical staining for POMC was carried out (POMC rabbit polyclonal antibody, 1:5000, Phoenix). 
For quantitative analysis, brain slices images (2088 × 1550 pixels) in the area of the ARC were captured using the 
x10 objective of a Zeiss Axioplan microscope equipped with a digital camera (Leica DFC 320, Wetzlar, Germany).
Morphometric analysis of Iba1 stained microglia. 3 images of each half of the arcuate nucleus from each of 3 
different slices/mouse and 2 images of LH, DMH, VMDMH and VMH from each of three different slices/mouse 
were taken. The size of the fields analysed was 173 μm × 218 μm. 5 mice per group were analysed. Morphological 
analyses was performed in a double blind manner. ImageJ software was used to measure immunoreactivity 
through a threshold method and the number of positive pixels and the extension of area of interest were used to 
determine the fractional area covered by the specific signal.
Quantification of AgRP positive puncta. 3 images of each half of the arcuate and paraventricular nucleus from 
each of 3 different slices/mouse were taken. The size of the fields analysed was 173 μm × 218 μm. 5 mice per group 
were analysed. The number of AgRP positive synaptic puncta was quantified by sharpening the contour with 
the software Axiovision 4.6.3 and then using the plugin Puncta Analyzer (written by Bary Wark, available upon 
request, c.eroglu@cellbio.duke.edu) under the ImageJ analysis software platform.
Quantification of POMC positive puncta. 2 images of each half of the arcuate from each of 4 different slices/
mouse were taken. 3 mice per group were analysed. ImageJ software was used to quantify the number of POMC 
positive synaptic puncta.
Cell culture. The N9 microglia cells were developed by immortalizing mouse primary microglia cells with 
the v-myc or v-mil oncogenes of the avian retrovirus MH282. This cell line displays several phenotypic traits of 
primary microglia mouse cells75. N9 cells were routinely maintained in Iscove’s Modified Dulbecco’s Medium 
(IMDM, Gibco by Life Technologies) supplemented with 1% antibiotic-antimycotic (Gibco by Life Technologies) 
and 10% Fetal Bovine Serum (Sigma-Aldrich).
For RNA extraction cells were plated at a density of 3.5 × 105 cells/well in 6-well plates. After 16 hours medium 
was changed and cells were treated with plasma as indicated for 6 hours and then lysed. Plasma for treatment was 
obtained from floxed and LERKO mice as described above, cells were treated with pools from 6–8 mice.
For TLR-4 experiments, cells were treated with the TLR-4 inhibitor TAK-242 (Calbiochem) 10 μM 1 hour 
before the treatment with mouse plasma.
Fatty acid profile by liquid chromatography-tandem mass spectrometry (LC-MS/MS). 20 μl of 
plasma from floxed and LERKO mice were added to 100 μl of MeOH:Acetonitrile 1:1 containing the internal 
standards (IS) [U-13C] linoleic acid (C18:2, Sigma Aldrich). Proteins were precipitated by centrifugation and the 
supernatant containing lipids was recovered. For the quantification of free fatty acids an aliquot of the supernatant 
was directly analyzed as described below.
Total fatty acids were obtained from samples by acid hydrolysis. Specifically, an aliquot of remaining super-
natant was resuspended in equal volume of chloroform/MeOH 1:1 v/v. and of 1 M HCl:MeOH (1:1, v/v) and 
shaken for 2 h. Then, chloroform:water (1:1 v/v) was added (equal volume of the starting supernatant) and the 
lower organic phase was collected, transferred into a new tube and dried under nitrogen flow. The residue was 
then resuspended in MeOH.
For fatty acid quantification, aliquots of each sample were diluted 1:10 in MeOH/water (50:50 v/v), transferred 
into a 96 well-plate and placed in a HTS-CTC PAL auto-sampler for LC–MS/MS analysis. Quantitative analysis 
was performed with calibration curves prepared and analyzed daily by electrospray ionization (ESI) using an API 
4000 triple quadrupole instrument (AB Sciex, USA). The LC mobile phases were: water/10 mM isopropylethyl-
amine/15 mM acetic acid (phase A) and MeOH (phase B). The gradient (flow rate 0.5 ml/min) was as follows: T 
0: 20% A, T 20: 1% A, T 25: 1% A, T 25.1: 20% A, T 30: 20% A. The Hypersil GOLD C8 column (100 mm × 3 mm, 
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3 μm) was maintained at 40 °C. The mass spectrometer was operated in selective ion monitoring (SIM)/SIM 
mode. Data were obtained using Multiquant software (AB Sciex, USA).
Statistical analysis. Statistical Analyses—Data are represented as mean ± S.E.M and statistical significance 
was verified using GraphPad Prism 5 ® software (GraphPad Software, San Diego, CA). Statistical significance 
was assessed by two-tailed unpaired t test for comparisons between two groups, one-way or two-way ANOVA 
followed by Bonferroni or Newman-Keuls post hoc tests were used for comparisons of multiple groups.
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